Press Releases

Lexicon Pharmaceuticals to Present at Upcoming Investor Conference	Aug 30, 2018
Lexicon Pharmaceuticals to Present at Upcoming Investor Conference	Aug 22, 2018
Lexicon Pharmaceuticals to Present at Upcoming Investor Conference	Jul 31, 2018
Lexicon Pharmaceuticals Reports Second Quarter 2018 Financial Results and Provides a Business Update	Jul 30, 2018
Lexicon Pharmaceuticals to Host Second Quarter 2018 Financial Results Conference Call and Webcast on July 30, 2018	Jul 23, 2018
Lexicon Pharmaceuticals Announces Positive 52-week Results from Sotagliflozin inTandem1 Study Presented at ADA 2018 and Published in Diabetes Care	Jun 24, 2018
Lexicon Pharmaceuticals Announces Positive 52-week Results from Sotagliflozin inTandem2 Study Presented at ADA 2018 and Published in Diabetes Care	Jun 23, 2018
Lexicon Pharmaceuticals to Present New Clinical Data at 78th American Diabetes Association Scientific Sessions	Jun 18, 2018
Lexicon Pharmaceuticals to Present at Upcoming Investor Conference	Jun 05, 2018
FDA to Review Zynquista™ (sotagliflozin) as Potential Treatment for Type 1 Diabetes	May 22, 2018